Journals / The Anatolian Journal of Cardiology / 2018 / Cilt: 19 - Sayı: 4

Atrial fibrillation and percutaneous coronary intervention: Are newer antithrombotic agents better for older patients?

Pages
291–291
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗

Özet

-

🔖

Cite This Article

LEGGIO, M., FUSCO, A., EMİDİO, S. D., SEVERİ, P., BENDİNİ, M. G., MAZZA, A. (2018). Atrial fibrillation and percutaneous coronary intervention: Are newer antithrombotic agents better for older patients?. The Anatolian Journal of Cardiology, Cilt: 19 - Sayı: 4, 291–291. https://ajindex.com/articles/367285

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, et al; RE-DUAL PCI Steering Committee and Investigators. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med 2017; 377: 1513-24. [CrossRef] Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, et al. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. N Engl J Med 2016; 375: 2423-34. [CrossRef] Bhatt DL. Intensifying platelet inhibition--navigating between Scylla and Charybdis. N Engl J Med 2007; 357: 2078-81. [CrossRef] Bhatt DL, Hulot JS, Moliterno DJ, Harrington RA. Antiplatelet and anticoagulation therapy for acute coronary syndromes. Circ Res 2014; 114: 1929-43. [CrossRef] Cavallari I, Patti G. Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation. Anatol J Cardiol 2018; 19: 67-71.